The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

By Özdemir Nuriye   Abalı Hüseyin   Öksüzoğlu Berna   Budakoglu Burçin   Uncu Doğan   Güler Tunç   Odabaşı Hatice   Zengin Nurullah  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 680-684

Humana Press, Inc

Access to resources Recommend Favorite

A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 143-144

Informa Healthcare

Access to resources Recommend Favorite

Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model

By Uchida N.   Takeda Y.   Hojo K.   Maekawa R.   Sugita K.   Yoshioka T.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1796-1801

Elsevier

Access to resources Recommend Favorite

Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells

By                      

International Journal of Oncology, Vol. 41, Iss. 3, 2012-01 ,pp. : 1148-1156

Spandidos Publications

Access to resources Recommend Favorite

The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors

By Kogure Takayuki   Ueno Yoshiyuki   Iwasaki Takao   Shimosegawa Toru  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 296-304

Springer Publishing Company

Access to resources Recommend Favorite